Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Davison

Showing results (401-410 of 451) with videos related to

Pageof 46
Sort By:
European Heart Journal|May 2, 2017
Biased ligand of the angiotensin II type 1 receptor in patients with acute heart failure: a randomized, double-blind, placebo-controlled, phase IIB, dose ranging trial (BLAST-AHF)Peter S Pang, Javed Butler, Sean P Collins, et al.
International Journal of Cardiology|January 8, 2018
Site enrollment rate, outcomes, and study drug effects in a multicenter trial. Results from RELAX-AHFMarco Metra, Beth A Davison, Claudio Gimpelewicz, et al.
JACC. Heart Failure|February 5, 2015
Heart failure therapeutics on the basis of a biased ligand of the angiotensin-2 type 1 receptor. Rationale and design of the BLAST-AHF study (Biased Ligand of the Angiotensin Receptor Study in Acute Heart Failure)G Michael Felker, Javed Butler, Sean P Collins, et al.
Circulation. Heart Failure|September 9, 2011
Impact of serial troponin release on outcomes in patients with acute heart failure: analysis from the PROTECT pilot studyChristopher M O'Connor, Mona Fiuzat, Carlo Lombardi, et al.
European Journal of Heart Failure|June 18, 2015
Early vs. late worsening heart failure during acute heart failure hospitalization: insights from the PROTECT trialRobert J Mentz, Marco Metra, Gad Cotter, et al.
Scientific Reports|November 25, 2024
The genome of the simultaneously hermaphroditic snail Lymnaea stagnalis reveals an evolutionary expansion of FMRFamide-like receptorsJ M Koene, D J Jackson, Y Nakadera, et al.
American Heart Journal|August 2, 2017
Effects of serelaxin on the outcome of patients with or without substantial peripheral edema: A subgroup analysis from the RELAX-AHF trialClaudio Gimpelewicz, Marco Metra, John G F Cleland, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 8, 2017
Relationship between baseline systolic blood pressure and long-term outcomes in acute heart failure patients treated with TRV027: an exploratory subgroup analysis of BLAST-AHFGad Cotter, Beth A Davison, Javed Butler, et al.
European Journal of Heart Failure|March 3, 2017
Plasma biomarkers to predict or rule out early post-discharge events after hospitalization for acute heart failureBiniyam G Demissei, Douwe Postmus, John G Cleland, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 23, 2015
Gender differences in clinical characteristics and outcome of acute heart failure in sub-Saharan Africa: results of the THESUS-HF studyOkechukwu S Ogah, Beth A Davison, Karen Sliwa, et al.
Pageof 46

Showing results (401-410 of 451) with videos related to

Sort By:
Pageof 46
European Heart Journal|May 2, 2017
Biased ligand of the angiotensin II type 1 receptor in patients with acute heart failure: a randomized, double-blind, placebo-controlled, phase IIB, dose ranging trial (BLAST-AHF)Peter S Pang, Javed Butler, Sean P Collins, et al.
International Journal of Cardiology|January 8, 2018
Site enrollment rate, outcomes, and study drug effects in a multicenter trial. Results from RELAX-AHFMarco Metra, Beth A Davison, Claudio Gimpelewicz, et al.
JACC. Heart Failure|February 5, 2015
Heart failure therapeutics on the basis of a biased ligand of the angiotensin-2 type 1 receptor. Rationale and design of the BLAST-AHF study (Biased Ligand of the Angiotensin Receptor Study in Acute Heart Failure)G Michael Felker, Javed Butler, Sean P Collins, et al.
Circulation. Heart Failure|September 9, 2011
Impact of serial troponin release on outcomes in patients with acute heart failure: analysis from the PROTECT pilot studyChristopher M O'Connor, Mona Fiuzat, Carlo Lombardi, et al.
European Journal of Heart Failure|June 18, 2015
Early vs. late worsening heart failure during acute heart failure hospitalization: insights from the PROTECT trialRobert J Mentz, Marco Metra, Gad Cotter, et al.
Scientific Reports|November 25, 2024
The genome of the simultaneously hermaphroditic snail Lymnaea stagnalis reveals an evolutionary expansion of FMRFamide-like receptorsJ M Koene, D J Jackson, Y Nakadera, et al.
American Heart Journal|August 2, 2017
Effects of serelaxin on the outcome of patients with or without substantial peripheral edema: A subgroup analysis from the RELAX-AHF trialClaudio Gimpelewicz, Marco Metra, John G F Cleland, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 8, 2017
Relationship between baseline systolic blood pressure and long-term outcomes in acute heart failure patients treated with TRV027: an exploratory subgroup analysis of BLAST-AHFGad Cotter, Beth A Davison, Javed Butler, et al.
European Journal of Heart Failure|March 3, 2017
Plasma biomarkers to predict or rule out early post-discharge events after hospitalization for acute heart failureBiniyam G Demissei, Douwe Postmus, John G Cleland, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 23, 2015
Gender differences in clinical characteristics and outcome of acute heart failure in sub-Saharan Africa: results of the THESUS-HF studyOkechukwu S Ogah, Beth A Davison, Karen Sliwa, et al.
Pageof 46